Clinical Trial Update: Metabolic Effects of Duodenal Jejunal Bypass Liner for Type 2 Diabetes Mellitus

View source ↗

Summary

A completed clinical trial update examining the metabolic effects of the duodenal-jejunal bypass liner in individuals with type 2 diabetes mellitus and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Type 2 Diabetes Mellitus, Obesity | Status: COMPLETED